Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study is to compare a minimally invasive surgical procedure and medication management in stroke patients with Atrial Fibrillation. The two treatment options are a minimally invasive surgical procedure or the use of medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Mar 2010
Longer than P75 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 5, 2010
CompletedFirst Posted
Study publicly available on registry
September 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedResults Posted
Study results publicly available
July 23, 2015
CompletedJuly 23, 2015
July 1, 2015
3.7 years
October 5, 2010
February 24, 2015
July 17, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of Life RAND 36-Item Health Survey
Compare quality of life of patient satisfaction between the surgery and or the medication in stroke patients with AF (atrial fibrillation). The RAND 36-Item Health Survey taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. Note that all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. Items in the same scale are averaged together to create the 8 scale scores which will have a 0 to 100 range.
Change in baseline, 3 month, and 6 month
Other Outcomes (9)
STAI-FormY-1 Questionnaire (State-Trait Anxiety Inventory)
Change in baseline, 3 month, and 6 month
STAI-Form-Y2 Questionnaire (State-Trait Anxiety Inventory)
Change in baseline, 3 month, and 6 month
Montreal Cognitive Assessment (Moca)
Change in baseline, 3 month, and 6 month
- +6 more other outcomes
Study Arms (2)
Minimally Invasive Surgery
ACTIVE COMPARATORThumb sized incisions are made on each sides of the chest wall where instruments are placed in the chest to perform the surgery.
Medical Therapy
ACTIVE COMPARATORPatients are treated with rhythm and rate control medications.
Interventions
Small thumb sized incisions are made on each side of the chest wall where instruments are inserted for the purpose of completing the surgery.
Patients are treated with rhythm and rate control medications.
Eligibility Criteria
You may qualify if:
- Patients with a history of stroke and paroxysmal, persistent or permanent AF.
- Eligible symptoms INCLUDE hemiplegia or hemiparesis, monoplegia, or language disturbance other than isolated dysarthria.
- Symptoms that will NOT QUALIFY AS TIA INCLUDE transient monocular blindness in both eyes, dysarthria, vertigo,isolated sensory symptoms, confusion, memory loss, nonspecific complaints of dizziness, or syncope.
You may not qualify if:
- Recent stroke (\< 1 month).
- Age \< 18 or \> 80 years; Ejection Fraction \< 25%• Presence of left atrial appendage thrombus on CT or echocardiography
- Previous empyema or thoracic surgery, preventing access to the pulmonary veins via thoracoscopy.
- Left Atrial Diameter \> 55mm.
- Contraindication to anticoagulation with Coumadin.
- Mitral insufficiency (\> 2+)
- • Contraindications to MRI
- Artificial heart valve prosthesis
- Aneurysm clips
- Implanted drug infusion device or pump
- Any type of neurotranstimulator
- Any type of bone growth stimulator
- Cochlear implants or inner ear prosthesis
- Any intravascular coils, filters, or stents
- Shrapnel or bullets
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Thomas Beaver
- Organization
- UF Healthcare
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Beaver, MD
University of Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2010
First Posted
September 28, 2011
Study Start
March 1, 2010
Primary Completion
November 1, 2013
Study Completion
November 1, 2014
Last Updated
July 23, 2015
Results First Posted
July 23, 2015
Record last verified: 2015-07